Brooks Laboratories Q3 Results

  • BSE: 533543
  • NSE: BROOKS
  • ISIN: INE650L01011
  • Sector: Major Drugs
BSE
143.82.80 (1.99%)
Volume9.84 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
142.82.80 (2.00%)
Volume17.09 K
Updated: Mon 25 Nov, 2024 | 15:15:10
Today: 138.50
143.80
52-Wk: 72.51
185.15

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Brooks Laboratories Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 21.7524.32-%15.30-%
    Selling/ General/ Admin Expenses Total 2.842.65-%4.14-%
    Depreciation/ Amortization 0.430.44-%2.33-%
    Other Operating Expenses Total 2.352.49-%8.21-%
    Total Operating Expense 21.0923.04-%25.83-%
    Operating Income 0.661.27-%-10.53-%
    Net Income Before Taxes -3.85-1.64-%-11.18-%
    Net Income -3.88-1.64-%-5.02-%
    Diluted Normalized EPS -1.51-0.64-%-2.10-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts